Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): A multicenter, double-blind, prospective trial
Z. F. Jiang*, M. Cristofanilli, Z. M. Shao, Z. S. Tong, E. W. Song, X. J. Wang, N. Liao, X. C. Hu, Y. Liu, Y. Wang, L. Zeng, M. Zhang
Dive into the research topics of 'Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): A multicenter, double-blind, prospective trial'. Together they form a unique fingerprint.